Navigation Links
West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase
Date:2/19/2008

A Night at the Museum to be held April 17, 2008

GRAND RAPIDS, Mich., Feb. 19 /PRNewswire/ -- The West Michigan Science & Technology Initiative (WMSTI) is accepting exhibitor applications from life science companies for the fourth annual Life Science Business Showcase, Night at the Museum, to be held Thursday, April 17 at 6:30 p.m.

Night at the Museum is seeking regional exhibitors from across the life science spectrum, ranging from up-and-coming startups in pharma research to established manufacturers of specialty medical devices. WMSTI's annual event will be held at the Urban Institute for Contemporary Arts (UICA) in downtown Grand Rapids and provides life science companies the opportunity to display their work to a targeted audience of key business leaders from across Michigan. Last year's Showcase drew more than 500 attendees and included over 50 exhibitors.

"We have a limited number of exhibitor opportunities remaining and are urging interested companies to secure their spots as soon as possible. It has been a very active year for the life science community across West Michigan, and WMSTI's annual showcase gives organizations a unique opportunity to highlight their progress," said Linda Chamberlain, executive director of WMSTI. "WMSTI and its partners are very proud of the event's established reputation as the premiere gathering of community leaders and life science innovators."

Night at the Museum event sponsors are Autocam Medical, Axios Incorporated, Inrad, MEDC, Michigan Radio, MSU College of Human Medicine, Rose Technologies, Saint Mary's Health Care, Smith Haughey Rice & Roegge, Spectrum Health, Van Andel Institute, Warner Norcross & Judd and WZZM 13.

Companies interested in exhibiting at the Life Science Business Showcase should visit http://showcase.wmsti.org for more information. The fee to exhibit is $350 and includes exhibit space, two tickets to
'/>"/>

SOURCE West Michigan Science & Technology Initiative
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. Michigan Life Sciences Pipeline to Kick Off MichBio Expo
3. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
4. MichBio Announces Student Career Day at Michigan State University
5. Michigan Life Science Network to Form Two New Virtual Companies
6. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
7. Michigan Life Science Network: Virtual Companies Get Global Reception
8. Ann Arbor SPARK Receives $3.75M from Michigans Company Formation & Growth Fund
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
11. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...alif., Nov. 6 Intarcia Therapeutic...TCA 650 (DUROS® continuous delivery of exenat...at the Ninth Annual Diabetes Technology Meeting in...om.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, ... ITCA 650 Lowers Plasma Glucose, HbA1c and Reduces...
(Date:11/5/2009)..., N.J., Nov. 5 DSM Pharmaceutical ...cturing alliance with Galenix, Saint Jean D,Illac,...l scale manufacturing partner for Galenix commerci...ix will collaborate on business development opport...ogies, based on the strength of Galenix in drug pr...
(Date:11/5/2009)...N.Y., Nov. 5 BioSpecific...ceutical company developing first-in-class collage... results for the third quarter ended September 30,...ptember of this year, the FDA,s Arthritis Advisory...2-0, the approval of XIAFLEX(TM) for the treatment...
(Date:11/5/2009)...xas, Nov. 5 SpineSmith Partners ha...to co-develop a unique scaffold that mimics the st...luation of several commercial products by SpineSmi...any believes the GenOsteo scaffold represents a si... unique and ideal environment for the delivery of ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...lopers will have the chance to combine their ideas...st annual Games+Learning+Society conference at t...being held by Games And Professional Practice Simu...Distributed Learning (ADL) Co-Lab and a group of i...Speakers include educators and developers from com...
...terman, here are the top 10 reasons to be at the B...hiladelphia. , , 10. You can pick up some great to...he coin of the realm in the BIO exhibit floor, whe...e set up shop. Mini-soccer balls, mini-Capitol dom... Crowd at BIO 9. You can go on a diet. Believe ...
... of GE Healthcare Technologies in Waukesha, will b...on next year as part of the parent company,s effor...n will succeed Bill Castell as head of GE Healthca... of the Waukesha-based GE Healthcare Technologies ... after Immelts promotion to succeed Jack Welch as ...
Other Biology Technology:Education conference to draw together games researchers 2From the BIO floor 2From the BIO floor 3
(Date:11/5/2009)...tate University has been awarded a training grant ...e Foundation under its Integrative Graduation Educ...is the first IGERT grant to be awarded to Kent Sta...Recovery and Reinvestment Act of 2009, runs throug...focuses on environment aquatic resource sensing (E...
(Date:11/4/2009)...ver, BC - Lowly bacteria, it turns out, hold the p...g plants around the world clean up toxic waste on ...cifically RDX, were invented back in World War II ...es. These high-energy compounds are often used to...ersion of TNT. , But with increased knowledge ...
(Date:11/4/2009)...DWOOD CITY, Calif., Oct. 20 Digita...nd authentication solutions, today announced that ...ale (POS) software for quick-service restaurants, ...r NextGen POS and Classic POS solutions. WAND,s qu...etrics to boost cashier accountability and deter u...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal 28TM 29 for the Treatment of Fabry Disease 4624 1Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal 28TM 29 for the Treatment of Fabry Disease 4624 2Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal 28TM 29 for the Treatment of Fabry Disease 4624 3Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal 28TM 29 for the Treatment of Fabry Disease 4624 4Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal 28TM 29 for the Treatment of Fabry Disease 4624 5Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal 28TM 29 for the Treatment of Fabry Disease 4624 6Geographic profiling applied to track hunting patterns of white sharks in South Africa 8945 1Geographic profiling applied to track hunting patterns of white sharks in South Africa 8945 2Verenium and Add Food Service GmbH Announce Commercial Distribution Partnership for Fuelzyme 28R 29 and Veretase 28TM 29 Enzymes 49583 1Verenium and Add Food Service GmbH Announce Commercial Distribution Partnership for Fuelzyme 28R 29 and Veretase 28TM 29 Enzymes 49583 2Verenium and Add Food Service GmbH Announce Commercial Distribution Partnership for Fuelzyme 28R 29 and Veretase 28TM 29 Enzymes 49583 3Verenium and Add Food Service GmbH Announce Commercial Distribution Partnership for Fuelzyme 28R 29 and Veretase 28TM 29 Enzymes 49583 4Verenium and Add Food Service GmbH Announce Commercial Distribution Partnership for Fuelzyme 28R 29 and Veretase 28TM 29 Enzymes 49583 5
...ifying Bacillus anthracis, the causative agent of ...e U.S. Food and Drug Administration (FDA). The tes... scientists at the U.S. Army Medical Research Inst... its performance and reliability when used with cl...hage Assay was first developed by the Centers for ...
...r Mark Pagani in the Department of Geology and Geo...t detailed history of atmospheric carbon dioxide b...sotopes of carbon in a National Science Foundation... energy we consume, each of us makes a contributio...dioxide and methane, in the Earth,s atmosphere," s...
...ly notice if the outside world suddenly went dark ...ur blinks, even though they cause a similar reduct...y are we not aware of the frequent mini-blackouts ...vered that visual sensitivity begins decreasing im... underlying this process have until now remained u...
Other Biology News:Anthrax test, developed by army and CDC, receives FDA approval 2Anthrax test, developed by army and CDC, receives FDA approval 3Invasive parasite destroying fish species 2Blink, and the brain misses it 2
Mouse Anti-Simian Virus 5 Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Simian Virus 5 Monoclonal Antibody, FITC Conjugated from AbD Serotec
Mouse Anti-Human MBP aa67-74 Monoclonal Antibody, Unconjugated from AbD Serotec
...cDNA Purification Kit is designed to purify double...ions such as cDNA synthesis and PCR. The process i...o 3 g can be efficiently purified and concentrated...1) DNA is bound to the Microfilter Cartridge in th...
Biology Products: